Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis
Authors:
Open Access
- 1 September 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (39) , e4624
Abstract
Recently, several studies reported increased signal intensity (SI) in the dentate nucleus (DN) after repeated application of gadolinium-based contrast agents (GBCAs), suggesting a deposition of gadolinium in this location. Patients with relapsing-remitting multiple sclerosis (RRMS) frequently show increased permeability of the blood-brain barrier as part of the inflammatory process in the brain parenchyma, which theoretically might increase the risk of gadolinium deposition. In this retrospective study, we investigated a possible increasing SI in the DN after repeated administrations of the macrocyclic contrast agent gadoterate meglumine.Forty-one RRMS patients (33 women, mean age 38 years) with at least 6 prior gadolinium-enhanced examinations (single dose gadoterate meglumine) were identified. A total of 279 unenhanced T1-weighted examinations were analyzed.SI ratio differences did not differ between the first and last MRI examination, neither for the DN-to-pons ratio (P = 0.594) nor for the DN-to-cerebellum ratio (P = 0.847). There was no correlation between the mean DN-to-pons, or between the mean DN-to-cerebellum SI ratio and the number of MRI examinations (P = 0.848 and 0.891), disease duration (P = 0.676 and 0.985), and expanded disability status scale (EDSS) (P = 0.639 and 0.945).We found no signal increases in the DN after a minimum of 6 injections of the macrocyclic GBCA gadoterate meglumine in RRMS patients. This warrants further investigations in regard to the true pathophysiologic basis of intracerebral gadolinium deposition.Keywords
This publication has 25 references indexed in Scilit:
- In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agentsEuropean Radiology, 2016
- High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted ImagesInvestigative Radiology, 2015
- Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine AdministrationInvestigative Radiology, 2015
- What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?European Radiology, 2015
- Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass SpectroscopyRadiology, 2015
- Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast AgentRadiology, 2015
- MRI pattern in asymptomatic natalizumab-associated PMLJournal of Neurology, Neurosurgery & Psychiatry, 2014
- MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervalsNeurology, 2003
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- The evolution of multiple sclerosis lesions on serial MR.1995